COLUMVI (glofitamab-gxbm) injection
Columvi is a cancer medicine used to treat adults with a blood cancer called diffuse large B-cell lymphoma (DLBCL) whose cancer has returned (relapsed) or stopped responding (refractory) after at least two previous treatments. FDA approved glofitamab-gxbm (brand name COLUMVI) is not (yet) registered or available in India but on request Indian patient can buy COLUMVI at the lowest price.
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
COLUMVI (glofitamab-gxbm) injection
Glofitamab-gxbm is approved to treat: B-cell non-Hodgkin lymphoma (NHL) that has come back or did not get better after at least two other systemic therapies. It is used in adults with the following types of B-cell NHL: Diffuse large B-cell lymphoma (DLBCL).
The Food and Drug Administration (FDA) has granted accelerated approval to Columvi® (glofitamab-gxbm) for the treatment of adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) not otherwise specified or large B-cell lymphoma (LBCL) arising from follicular lymphoma, after 2 or more lines of systemic therapy.
Glofitamab, sold under the brand name Columvi, is a bispecific monoclonal antibody used for the treatment of large B-cell lymphoma.[10] It is a bispecific CD20-directed CD3 T-cell engager.
It was approved for medical use in Canada in July 2023, in the United States in June 2023, and in the European Union in July 2023.
Glofitamab is indicated for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma. Specifically it is indicated for the treatment of adults with certain types of diffuse large B-cell lymphoma or large B-cell lymphoma who have received at least two prior treatments that did not work or are no longer working.
Drug (Brand / Generic): COLUMVI /glofitamab-gxbm
Current Indication: treat large B-cell lymphoma
Approval Date: 2023
Injection:
2.5 mg/2.5 mL (1 mg/mL) in a single-dose vial.
10 mg/10 mL (1 mg/mL) in a single-dose vial.
Find Reference Updates
- For COLUMVI (glofitamab-gxbm) injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions.
- Columvi Approved for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- FDA Approves Glofitamab (Columvi) for DLBCL
- Roche’s Columvi receives marketing approval in Europe
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ COLUMVI (glofitamab-gxbm) injection ”. FDA approved glofitamab-gxbm (brand name COLUMVI) is not (yet) registered or available in India but on request Indian patient can buy COLUMVI at the lowest price. Confirmation of the order for COLUMVI (glofitamab-gxbm) injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Get Access to FDA approved glofitamab-gxbm (brand name COLUMVI) India.
We have delivered medicines to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
COLUMVI Sourcing & Delivery
Alleviare India specializes in sourcing and supplying COLUMVI , a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of COLUMVI in India.
How much does COLUMVI cost in the India?
Kindly reach out to us for COLUMVI (glofitamab-gxbm) injection price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
What documents are required to import COLUMVI to India?
To import glofitamab-gxbm COLUMVI, patients or government hospitals can place an order on behalf of the patients. The following documentation is required for the import process:
- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
- Valid prescription from the doctor.
- Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is COLUMVI available in India?
COLUMVI glofitamab is a prescription medication, which means it legally requires a medical prescription to be dispensed. Alleviare India assists in importing cancer medicines through the named patient supply (NPS) program. They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune. Alleviare ensures 100% transparency and helps find genuine and reliable sources from Canada, Europe, USA, and Australia. They can facilitate the supply of COLUMVI (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements.
Please contact or mail @ – info@alleviareindia.com +91 9289711087 / 9289711088 for COLUMVI availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is glofitamab available in India?
Yes, FDA approved glofitamab-gxbm (brand name COLUMVI) is not (yet) registered or available in India but on request Indian patient can buy COLUMVI at the lowest price. Alleviare will help patient / doctor to get in India.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand COLUMVI (glofitamab-gxbm) injection . The import process requires a valid prescription and an Import License in the Patient’s Name.
